Evidence map›Paper›PMID 34099862›Full record

ArticleCommunications biology2021

REG3A/REG3B promotes acinar to ductal metaplasia through binding to EXTL3 and activating the RAS-RAF-MEK-ERK signaling pathway.

Huairong Zhang, Andrea Liliam Gomez Corredor, Julia Messina-Pacheco, Qing Li, George Zogopoulos, Nancy Kaddour, Yifan Wang, Bing-Yin Shi, Alex Gregorieff, Jun-Li Liu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Huairong Zhang *Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Andrea Liliam Gomez Corredor *Department of Pathology, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada.
Julia Messina-Pacheco *Department of Pathology, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada.ORCID 0000-0002-1065-1945
Qing LiHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA.
George ZogopoulosDepartment of Surgery, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada.
Nancy KaddourDepartment of Medicine, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada.
Yifan WangDepartment of Surgery, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada.
Bing-Yin ShiDepartment of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Alex GregorieffDepartment of Pathology, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada.ORCID 0000-0002-5416-3492
Jun-Li LiuDepartment of Medicine, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada. jun-li.liu@mcgill.ca.ORCID 0000-0001-6251-6406
Zu-Hua GaoDepartment of Pathology, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada. zu-hua.gao@mcgill.ca.ORCID 0000-0001-7232-0933
McGill University Health Centre · CAFirst Affiliated Hospital of Xi'an Jiaotong University · CNMemorial Sloan Kettering Cancer Center · USShanghai Jiao Tong University · CN

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
CIHR PJ9-173593CIHR PJT-175208NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Persistent acinar to ductal metaplasia (ADM) is a recently recognized precursor of pancreatic ductal adenocarcinoma (PDAC). Here we show that the ADM area of human pancreas tissue adjacent to PDAC expresses significantly higher levels of regenerating protein 3A (REG3A). Exogenous REG3A and its mouse homolog REG3B induce ADM in the 3D culture of primary human and murine acinar cells, respectively. Both Reg3b transgenic mice and REG3B-treated mice with caerulein-induced pancreatitis develop and sustain ADM. Two out of five Reg3b transgenic mice with caerulein-induced pancreatitis show progression from ADM to pancreatic intraepithelial neoplasia (PanIN). Both in vitro and in vivo ADM models demonstrate activation of the RAS-RAF-MEK-ERK signaling pathway. Exostosin-like glycosyltransferase 3 (EXTL3) functions as the receptor for REG3B and mediates the activation of downstream signaling proteins. Our data indicates that REG3A/REG3B promotes persistent ADM through binding to EXTL3 and activating the RAS-RAF-MEK-ERK signaling pathway. Targeting REG3A/REG3B, its receptor EXTL3, or other downstream molecules could interrupt the ADM process and prevent early PDAC carcinogenesis.

Indexed as

AnimalsCarcinoma, Pancreatic DuctalCell Line, TumorHumansMaleMAP Kinase Signaling SystemMetaplasiaMiceMice, Inbred C57BLN-AcetylglucosaminyltransferasesPancreatic DuctsPancreatic NeoplasmsPancreatitis-Associated Proteinsraf Kinasesras ProteinsSignal TransductionEXTL3 protein, humanExtl3 protein, mouseN-AcetylglucosaminyltransferasesPancreatitis-Associated Proteinsraf Kinasesras ProteinsREG3A protein, humanReg3b protein, mouse

Identifiers

PMID34099862
PMCPMC8184755
OpenAlexW3170503528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.